Regulatory affairs

In 1978, Centaur Pharmaceuticals, commenced pharmaceutical manufacturing operations in Mumbai and has now evolved into a vertically integrated pharmaceutical company. Centaur House, our corporate headquarters, is located in Mumbai, the commercial capital of India. Centaur has a strong matrix of capabilities across the pharmaceutical value chain including API, formulations, Contract Research and Manufacturing Services, Clinical Research, R&D, regulatory and marketing.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.

Cubit life sciences LLP ISO certified, WHO Approved & State FDCA approved pharmaceutical manufacturing organization (Formerly Known as Cubit healthcare from 2002) was established in 2019 with a broad vision of providing world class quality medicines at affordable prices across India and to international market. CUBIT group of companies mainly involved in manufacturing and marketing of medicines with well-planned formulation and development for its own product and for companies associated with it as a business partner.

Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives.

Emcure Inviting Applications for RA - Officer / Executive.

VBPL is an ISO 13485:2012 and WHO – GMP certified leading global player in Biopharma sector having more than 15 years of operational experience, situated at Hyderabad. We also have offices located in USA. Innovative, ever motivated Research team and uncompromising manufacturing team in providing quality products are our strengths.

Post : Executive or Sr Executive-Regulatory Affairs

Sun Pharma is the fifth largest generic pharmaceutical company in the world. It is also India's largest and most valuable pharmaceutical enterprise by size and market capitalization. The company provides high-quality medicines trusted by customers and patients in over 150 countries and has multiple manufacturing facilities and R&D centres.

Opening in Regulatory Affairs - Branded

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Regulatory Affairs

Established during the Swadeshi Movement of India, Biological E. Limited (BE) started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.  With an objective of transitioning from treating diseases to preventing them, Biological E.

Stallion Laboratories incorporated in 1988 as an integrated private sector Pharmaceutical Formulation Manufacturer, has acquired an unmatched record of managing niche product in formulations with a WHO GMP approved production fatality and GLP qualified stringent quality control. The path of success lies in its belief of creativity and no negotiation with the quality of work. Stallion Laboratories is coming up with Unit II which is proposed to be UK-MHRA, EU GMP & PICS approved plant. With its approval. Stallion aims to enter regulated markets.